Vaccinating children against rotavirus in Bangladesh would prevent more than 50,000 outpatient visits and 40,000 hospitalizations in children under five each year, and reduce treatment costs by US$5.8 million over 2 years — nearly all (96%) from fewer hospitalizations. Since this study didn’t take herd effects into account, the actual impact would likely be greater.
Full Citation:
Sarker AR, Sultana M, Mahumud RA, et al.. 2018. Cost-effectiveness analysis of introducing universal childhood rotavirus vaccination in Bangladesh. Human Vaccines & Immunotherapeutics. 14(1).
Title of Article: Cost-effectiveness analysis of introducing universal childhood rotavirus vaccination in Bangladesh
Author(s): Sarker AR, Sultana M, Mahumud RA, et al.
Publication Year: 2018
Publication Name: Human Vaccines & Immunotherapeutics
Publication Volume: 14(1)
Publication Source URL: https://pubmed.ncbi.nlm.nih.gov/29099653/
DOI (Digital Object Identifier): 10.1080/21645515.2017.1356962
Topics: Economics & Return on Investment
Disease Vaccines: Rotavirus
Countries: Bangladesh
WHO Regions: South-East Asia